Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Raffaele Longo, Victoire Thiebaut, Pierre-Olivier Legros, Marco Campitiello, Francesca Plastino, Christophe Goetz, Bogdan Margineanu, Julie Pujois, Michel Gunther, Julie Egea & Chloé Wendel. (2022) Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study. Acta Oncologica 61:11, pages 1394-1399.
Read now
Read now
Dorthe Aamand Grabau, Pär-Ola Bendahl, Lisa Rydén, Olle Stål & Mårten Fernö. (2013) The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval – prognostic implications?. Acta Oncologica 52:8, pages 1657-1666.
Read now
Read now
Syed K. Mohsin & D. Craig Allred. (1999) Immunohistochemical Biomarkers in Breast Cancer. Journal of Histotechnology 22:3, pages 249-261.
Read now
Read now
Articles from other publishers (24)
Jacques Raphael, Sonal Gandhi, Nim Li, Fang-I Lu & Maureen Trudeau. (2017) The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Research and Treatment 164:2, pages 285-294.
Crossref
Crossref
Cheng-Har Yip & Anthony Rhodes. (2014) Estrogen and progesterone receptors in breast cancer. Future Oncology 10:14, pages 2293-2301.
Crossref
Crossref
O. Brouckaert, R. Paridaens, G. Floris, E. Rakha, K. Osborne & P. Neven. (2013) A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Annals of Oncology 24:1, pages 47-53.
Crossref
Crossref
S. Nofech-Mozes, E.T. Vella, S. Dhesy-Thind & W.M. Hanna. (2012) Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer. Clinical Oncology 24:10, pages 684-696.
Crossref
Crossref
Sharon Nofech-Mozes, Emily T. Vella, Sukhbinder Dhesy-Thind, Karen L. Hagerty, Pamela B. Mangu, Sarah Temin & Wedad M. Hanna. (2012) Systematic Review on Hormone Receptor Testing in Breast Cancer. Applied Immunohistochemistry & Molecular Morphology 20:3, pages 214-263.
Crossref
Crossref
Antonio C. Wolff & Mitch Dowsett. (2011) Estrogen Receptor: A Never Ending Story?. Journal of Clinical Oncology 29:22, pages 2955-2958.
Crossref
Crossref
Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy Fornander, Olle Stål, Lambert Skoog, Jonas Bergh & Bo Nordenskjöld. (2010) Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen. Breast Cancer Research and Treatment 126:2, pages 421-430.
Crossref
Crossref
David J. Dabbs. 2006. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry
699
745
.
Nidal M Almasri & Mohammad Al Hamad. (2005) Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan. Breast Cancer Research 7:5.
Crossref
Crossref
Edwin R. Fisher, Stewart Anderson, Scott Dean, David Dabbs, Bernard Fisher, Richard Siderits, Jeffrey Pritchard, Telma Pereira, Charles Geyer & Norman Wolmark. (2004) Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer 103:1, pages 164-173.
Crossref
Crossref
Anna Bladström, Harald Anderson & Håkan Olsson. (2003) Worse Survival in Breast Cancer Among Women with Recent Childbirth: Results from a Swedish Population-Based Register Study. Clinical Breast Cancer 4:4, pages 280-285.
Crossref
Crossref
L. Löfgren, L. Skoog, E. von Schoultz, E. Tani, E. Isaksson, R. Fernstad, K. Carlström & B. von Schoultz. (2003) Hormone receptor status in breast cancer - a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 14:3, pages 136-142.
Crossref
Crossref
Magali Ferrero-Poüs, Martine Trassard, Viviane Le Doussal, Kamel Hacène, Michèle Tubiana-Hulin & Frédérique Spyratos. (2001) Comparison of Enzyme Immunoassay and Immunohistochemical Measurements of Estrogen and Progesterone Receptors in Breast Cancer Patients. Applied Immunohistochemistry & Molecular Morphology 9:3, pages 267-275.
Crossref
Crossref
Magali Ferrero-Pous, Martine Trassard, Viviane Le Doussal, Kamel Hacene, Michele Tubiana-Hulin & Frederique Spyratos. (2001) Applied Immunohistochemistry 9:3, pages 267-275.
Crossref
Crossref
Anthony Rhodes, Bharat Jasani, Andre J. Balaton, Diana M. Barnes, Elizabeth Anderson, Lynda G. Bobrow & Keith D. Miller. (2001) Study of Interlaboratory Reliability and Reproducibility of Estrogen and Progesterone Receptor Assays in Europe. American Journal of Clinical Pathology 115:1, pages 44-58.
Crossref
Crossref
A Rhodes. (2000) Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. Journal of Clinical Pathology 53:9, pages 688-696.
Crossref
Crossref
A Rhodes. (2000) Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. Journal of Clinical Pathology 53:4, pages 292-301.
Crossref
Crossref
A Rhodes. (2000) Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. Journal of Clinical Pathology 53:2, pages 125-130.
Crossref
Crossref
Jennet M. HarveyGary M. ClarkC. Kent OsborneD. Craig Allred. (1999) Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer. Journal of Clinical Oncology 17:5, pages 1474-1474.
Crossref
Crossref
Louis P. Pertschuk & Constantine A. Axiotis. (2002) Steroid Hormone Receptor Immunohistochemistry in Breast Cancer: Past, Present, and Future. The Breast Journal 5:1, pages 3-12.
Crossref
Crossref
Aysegul A. Sahin & Vicente Valero. 1999. Breast Cancer. Breast Cancer
93
119
.
D.M Barnes, R.R Millis, L.V.A.M Beex, S.M Thorpe & R.E Leake. (1998) Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. European Journal of Cancer 34:11, pages 1677-1682.
Crossref
Crossref
Niklas Loman, Oskar Johannsson, P�r-Ola Bendahl, �ke Borg, M�rten Fern� & H�kan Olsson. (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:2, pages 310-319.
Crossref
Crossref
R.M. Parache & C. Migeon. (1996) Les récepteurs hormonaux par immunohistochimie dans les carcinomes mammaires. Revue Française des Laboratoires 1996:286, pages 149-155.
Crossref
Crossref